A survey of healthcare and life science professionals and investors suggests healthcare M&A activity will surge past 2013 levels when there were 394 deals valued at $97 billion. The report by Bass Berry & Sims and Mergermarket indicates that market disruption, brought on by the Affordable Care Act, will lead to more consolidation deals across healthcare facilities, life science and healthcare IT companies.
L'imagerie par résonance magnétique (IRM) est un outil spectroscopique très utilisé en clinique, mais ses capacités potentielles restent largement sous-exploitées. En cause : le manque de sensibilité de cette technique, qui ne peut s'appliquer qu'aux molécules les plus concentrées de notre corps, à savoir l'eau dans la plupart des cas. Depuis quelques années, pour pallier ce problème, la polarisation dynamique nucléaire est utilisée conjointement avec l'IRM dans le cadre de la recherche. Des chercheurs de l'Institut Weizmann sont allés encore plus loin, en associant ces deux techniques à une stratégie d'acquisition des données permettant de suivre le métabolisme en temps réel.
D'après des chercheurs de la faculté de médecine de l'Université hébraïque de Jérusalem, la protéine Erbin permet de prévenir l'hypertrophie cardiaque pathologique. Elle pourrait également jouer un rôle dans l'amélioration du traitement du cancer du sein.
Zurex Pharma, a Middleton, WI-based startup developing antimicrobial products to prevent hospital-acquired infections, has raised $4.1 million from investors in a round that could top out at $5.1 million, according to a new SEC filing.
There are 13 investors in the round, which appears to be the company’s Series B raise. Zurex officials couldn’t immediately be reached for comment.
New software could give people greater control over how their personal health information is shared between doctors and medical institutions—provided that enough health providers decide to use the system.
The digital health space has continued to heat up, and it’s looking like 2014 will be a big year for investment in the space.
A new Rock Health report says that halfway through 2014 more than $2.2B has been invested in digital health startups. That’s already more than the $1.97 billion invested in the space during all of 2013, and 2013 was a record year for funding in the space.
Year over year, the amount invested in digital health startups grew by more than 160 percent, the Rock Health report claims.
ReWalk, the Israeli-developed exoskeleton system that enables the paralyzed to walk, has been cleared for home use by the FDA, a key step toward supplying the device that has shown it can revolutionize the lives of war casualties and others who have lost the use of their legs.
Verizon tonight announced the launch of a new mobile health platform, Verizon Virtual Visits, which will let you set up a quick virtual appointment with doctors using your smartphone, computer, or tablet.
With the new platform, Verizon claims its the first large company to enter the telemedicine market (at the time of this post, I haven’t found any examples to prove otherwise). It also fits right alongside Verizon’s moves towards exploring new markets — like ways to utilize its LTE network for connected devices.
A cancer-detection technology that “sniffs out” malignant tumors is set to be commercialized, after a study showed that a device based on the Technion-developed “NaNose” system successfully detected lung cancer in patients with up to 90 percent accuracy. At the heart of the device — which looks like a “breathalyzer,” usually used to detect alcohol levels — is a chip based on the NaNose technology developed by
Uncomfortable cramping and bloating are just some of the symptoms that the millions suffering from constipation, the most common health disorder, experience. In fact over 42 million Americans, one-seventh of the population of the United States, are affected by the symptoms, pain and discomfort associated with constipation, a blocked up reality that can continue for weeks and even years.
